https://www.selleckchem.com/pr....oducts/Rapamycin.htm
randomised studies with adequate sample size are required. Many reports suggest more activity of cytotoxic chemotherapy among patients with metastatic colorectal cancer (mCRC) who experience neutropenia, but it is not clear whether this finding is related to drug effect alone. The aim of the study is to identify the characteristics of patients whose peripheral blood cell kinetics (PBCK) is related to the outcome. The study is a retrospective analysis of patients with mCRC who had received first-line chemotherapy at Sanremo hospital fr
Like
Comment
Share
